Q3 2018 Holdings
Filed 2018-11-07 | 14 holdings | $211.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Replimune(REPL) | Common Stock | 76029N106 | $82.2K | 5,103,455 | 38.9% |
| Paratek Pharmaceuticals | Common Stock | 699374302 | $25.2K | 2,600,410 | 11.9% |
| Translate Bio | Common Stock | 89374L104 | $24.4K | 2,437,601 | 11.5% |
| ObsEva | Common Stock | H5861P103 | $18.0K | 999,364 | 8.5% |
| Kezar Life Sciences | Common Stock | 49372L100 | $14.8K | 693,272 | 7.0% |
| Sienna Biopharmaceuticals(SNNAQ) | Common Stock | 82622H108 | $11.2K | 758,610 | 5.3% |
| FibroGen(FGENEUR) | Common Stock | 31572Q808 | $7.9K | 130,646 | 3.8% |
| Cidara Therapeutics | Common Stock | 171757107 | $6.6K | 1,508,794 | 3.1% |
| CymaBay Therapeutics(CBAYUSD) | Common Stock | 23257D103 | $6.1K | 551,477 | 2.9% |
| Pieris Pharmaceuticals | Common Stock | 720795103 | $4.4K | 778,230 | 2.1% |
| Jounce Therapeutics(JNCEEUR) | Common Stock | 481116101 | $3.4K | 529,965 | 1.6% |
| Dicerna Pharmaceuticals(DRNAUSD) | Common Stock | 253031108 | $3.4K | 223,457 | 1.6% |
| Essa Pharma(EPIEUR) | Common Stock | 29668H708 | $3.3K | 1,084,848 | 1.5% |
| Egalet | Common Stock | 28226B104 | $359 | 2,889,926 | 0.2% |